American College of Clinical Pharmacy
      Search      Cart
         
Schedule

The Pharmacotherapy Course will be held Saturday and Sunday, April 23–24, 2022, at the Univeristy of Health Sciences & Pharmacy in St. Louis, Missouri.

Click here to view/print the full meeting schedule.

ACCP Spring Forum Preparatory
Review and Recertification Courses
April 23–24, 2022

2022 Pharmacotherapy Preparatory Review and Recertification Course -- Pharmacokinetics: A Refresher, Nephrology, Oncology Supportive Care, and Gastrointestinal Disorders

Monday, April 25, 2022
Available for 4.00 hours of CPE credit
Activity Number: 0217-0000-22-015-H01-P

Pharmacotherapy Preparatory Review and Recertification Course is ideal for pharmacy professionals preparing for the Board of Pharmacy Specialties (BPS) Pharmacotherapy Specialty Certification Examination, for Board Certified Pharmacotherapy Specialists (BCPSs) seeking recertification through continuing education, and for those seeking a self-paced review and refresher of pharmacotherapy topics.

Developed and presented by board-certified pharmacotherapy specialists, the course provides a comprehensive review of the knowledge domains covered in the pharmacotherapy specialty. Using a case-based approach, the course strongly emphasizes the thought processes needed to solve patient care problems in each therapeutic area.

Learning Objectives

  1. Identify and solve pharmacotherapy problems using basic pharmacokinetic concepts, including bioavailability, volume of distribution, clearance, and the elimination rate constant.
  2. Describe clinically relevant issues related to drug transport proteins, cytochrome P450 metabolism, pharmacogenomics, and drug sampling and interpretation.
  3. Describe specific pharmacokinetic characteristics and target concentrations of commonly used therapeutic agents, including aminoglycosides, vancomycin, phenytoin, valproic acid, and digoxin, as well as pharmacokinetic alterations in patients with renal and hepatic disease.
  4. Categorize acute kidney injury (AKI) and chronic kidney disease (CKD) on the basis of patient history, physical examination, laboratory values, and risk factors.
  5. Formulate therapeutic plans to slow progression of CKD or decrease the risk of AKI.
  6. Develop a care plan to manage common complications observed in patients with CKD (e.g.- anemia, hyperphosphatemia, secondary hyperparathyroidism).
  7. Interpret results of clinical trials related to the treatment of patients with kidney disease or complications.
  8. Identify, assess, and recommend appropriate pharmacotherapy for managing common complications of cancer chemotherapy, including nausea and vomiting, myelosuppression and the appropriate use of growth factors, infection, anemia and fatigue, cardiotoxicity, and extravasation injury.
  9. Assess and recommend appropriate pharmacotherapy for managing cancer-related pain.
  10. Assess and recommend appropriate pharmacotherapy for managing oncologic emergencies, including hypercalcemia, tumor lysis syndrome, and spinal cord compression.
  11. Review national guideline treatment strategies for the following gastrointestinal (GI) disorders: gastroesophageal reflux disease (GERD); peptic ulcer disease (PUD); ulcerative colitis (UC); Crohn disease (CD); chronic liver disease, including viral hepatitis and cirrhosis; constipation; diarrhea; irritable bowel syndrome (IBS); nausea; vomiting; pancreatitis; and upper GI bleeding, including prevention of stress-related mucosal disease (SRMD).
  12. Recommend appropriate pharmacologic and nonpharmacologic interventions given a specific patient with one or more GI disorders.
  13. Recognize pertinent information for educating patients and prescribers regarding the appropriate use of pharmacologic agents for various GI disorders.
  14. Evaluate and apply evidence related to GI disorders for patient care, including appropriate interpretation or use of study designs and statistical tests.

Pharmacokinetics: A Refresher



Speakers

Speaker: Curtis L. Smith, Pharm.D., FCCP, BCPS
Professor
Ferris State University, College of Pharmacy
Clinical Pharmacist
Sparrow Health System
Lansing, Michigan

View Biography
Curtis L. Smith, Pharm.D., FCCP, BCPS
Smith

Nephrology



Speakers

Speaker: John M. Burke, Pharm.D., BCPS
Professor, Pharmacy Practice
University of Health Sciences & Pharmacy in St. Louis
St. Louis, Missouri

View Biography
John M. Burke, Pharm.D., BCPS
Burke
Speaker: Andrew J. Crannage, Pharm.D., FCCP, BCPS
Assistant Professor of Pharmacy Practice
St. Louis College of Pharmacy
St. Louis, Missouri

View Biography
Andrew J. Crannage, Pharm.D., FCCP, BCPS
Crannage

Oncology Supportive Care



Speakers

Speaker: Christopher T. Elder, Pharm.D., BCOP
Clinical Oncology Pharmacist
Florida Cancer Specialists and Research Institute
Adjunct Professor of Pharmacy Practice
Palm Beach Atlantic University
West Palm Beach, Florida

View Biography
Christopher T. Elder, Pharm.D., BCOP
Elder

Gastrointestinal Disorders



Speakers

Speaker: Sheila M. Wilhelm, Pharm.D., FCCP, BCPS

Clinical Professor and Coordinator of the Patient Care Laboratory

Wayne State University

Detroit, MI


View Biography
Sheila M. Wilhelm, Pharm.D., FCCP, BCPS
Wilhelm

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.